Putative uncharacterized protein ORFB in retron EC67 Antibody

What is the Putative uncharacterized protein ORFB in retron EC67?

The Putative uncharacterized protein ORFB is a component of retron EC67, a bacterial genetic element found in clinical isolates of Escherichia coli. This protein is encoded within a 34-kilobase sequence that has been mapped to a position equivalent to 19 minutes on the E. coli K-12 chromosome. The retron EC67 element is flanked by direct repeats of a 26-base-pair sequence found in K-12 chromosomal DNA, suggesting it was integrated into the E. coli genome through a mechanism related to transposition or phage integration . The full-length protein consists of 169 amino acids with the sequence starting with "MFDYQVSKHP" and ending with "ASFGLL" .

What are retrons and how does retron EC67 function in bacteria?

Retrons are bacterial genetic retroelements that encode reverse transcriptase capable of producing multicopy single-stranded DNA (msDNA) and function as antiphage defense systems . Specifically, retron EC67 is required for the biosynthesis of a branched-RNA-linked multicopy single-stranded DNA known as msDNA-EC67 . The retron defense system works by sensing phage infection and activating effector proteins that can inhibit phage replication. In the case of retron EC67, it appears to be triggered by the activity of specific phage proteins involved in DNA degradation, such as DenB in T2 phage and protein A1 in T5n/ΦSP15m phages .

What is the recommended protocol for reconstituting recombinant ORFB protein for experiments?

For optimal experimental use, the recombinant protein should be reconstituted following these steps:

• Briefly centrifuge the vial prior to opening to bring contents to the bottom

• Reconstitute the protein in deionized sterile water to a concentration of 0.1-1.0 mg/mL

• Add glycerol to a final concentration of 5-50% (50% is recommended as default)

• Aliquot for long-term storage at -20°C/-80°C to prevent repeated freeze-thaw cycles

• For working solutions, store aliquots at 4°C for up to one week

How should researchers design experiments to study retron EC67's antiphage activity?

When investigating retron EC67's antiphage defense capabilities, researchers should consider a multifaceted experimental approach:

• Phage Sensitivity Assays: Test the efficacy of retron EC67 against a panel of different phages, particularly focusing on T2, T5, and T-even phages, which have shown differential susceptibility. Record both complete inhibition and changes in plaque morphology/size.

• Component Analysis: Create mutants with modifications to key components of the retron system to determine essential elements. Based on similar retron systems, this should include:

  • Reverse transcriptase catalytic site mutations

  • msDNA production capability assessment

  • Effector protein function disruption

• Phage Escape Mutant Generation: Challenge bacteria expressing retron EC67 with high concentrations of phage to isolate escape mutants. Sequence these mutants to identify genetic determinants that trigger retron EC67 defense, focusing particularly on genes involved in DNA degradation like DenB and protein A1 .

• Molecular Interaction Studies: Investigate how the retron complex interacts with phage components through techniques such as pull-down assays, co-immunoprecipitation, or yeast two-hybrid systems to identify direct protein-protein interactions .

What are the optimal storage conditions for maintaining ORFB protein activity?

To maintain optimal activity of the Putative uncharacterized protein ORFB, follow these evidence-based storage protocols:

• Short-term storage (up to one week): Store working aliquots at 4°C

• Medium-term storage (up to 6 months): Store in liquid form at -20°C/-80°C with 50% glycerol

• Long-term storage (up to 12 months): Store in lyophilized form at -20°C/-80°C

• Avoid repeated freeze-thaw cycles: Each cycle can reduce protein activity

• Reconstitution recommendations: Use deionized sterile water rather than buffers containing potential interfering compounds

The stability of the protein is influenced by multiple factors including buffer ingredients and the inherent stability of the protein structure itself.

What methodologies are most effective for studying ORFB interactions with phage components?

To effectively study interactions between ORFB and phage components, consider these methodological approaches:

• Co-expression systems: Express ORFB alongside candidate phage proteins (particularly focusing on DNA degradation proteins like DenB or protein A1) in non-pathogenic E. coli strains to observe potential toxicity or functional interactions .

• Protein-protein interaction assays:

  • Pull-down assays using tagged ORFB

  • Surface plasmon resonance to measure binding kinetics

  • Bio-layer interferometry for real-time binding analysis

  • Cross-linking followed by mass spectrometry to identify interaction sites

• Functional activity assays:

  • Monitor changes in msDNA production when ORFB is exposed to phage components

  • Assess cell viability under different expression conditions

  • Measure bacterial growth curves during phage infection with and without functional ORFB

• Structural biology approaches:

  • X-ray crystallography or cryo-EM to determine ORFB structure and potential interaction domains

  • Hydrogen-deuterium exchange mass spectrometry to identify regions involved in protein-protein interactions

How does phage evasion of retron EC67 defense occur at the molecular level?

Research indicates that phage evasion of retron EC67 defense operates through multiple sophisticated mechanisms:

• Direct counterdefense proteins: Some phages encode specific proteins that can neutralize retron activity. For example, the Rad (retron anti-defense) protein has been identified in certain phages. Rad reduces msDNA and non-coding RNA (msr-msd transcriptional cassettes) of retrons but does not affect the transcript levels of reverse transcriptase and effector proteins. This suggests Rad specifically degrades the non-coding RNA components to prevent further synthesis and assembly of the retron complex .

• Genetic mutations in trigger proteins: Phages develop mutations in specific proteins that are sensed by retron EC67. Research has identified single point mutations in all escape mutants of T5n, ΦSP15m, and T2 phages. For T2 phages, mutations occur in the DenB gene, while T5n/ΦSP15m phages show mutations in protein A1. Both proteins are involved in DNA degradation activities, suggesting retron EC67 defense may be triggered by these DNA degradation activities rather than direct protein recognition .

• Alternative anti-retron mechanisms: Phages like T4 and T6 show reduced susceptibility to retron EC67 despite genetic similarity to T2, suggesting they may possess alternative anti-retron mechanisms distinct from Rad proteins. The exact nature of these alternative mechanisms remains an active area of research .

What is the evolutionary relationship between retron EC67 and other bacterial defense systems?

The evolutionary trajectory of retron EC67 can be understood within the broader context of bacterial defense systems:

• Integration mechanism similarities: The retron EC67 element consists of a 34-kilobase sequence flanked by direct repeats of a 26-base-pair sequence found in K-12 chromosomal DNA. This structural feature suggests integration through transposition or phage integration mechanisms, representing horizontal gene transfer events in bacterial evolution .

• Related methylase functions: Within the 34-kilobase sequence of retron EC67, an open reading frame of 285 residues exhibits 44% sequence identity with E. coli Dam methylase. This methylase connection is further strengthened by the presence of three GATC sequences (Dam methylation sites) in the promoter region of the reverse transcriptase gene. This suggests potential regulatory connections between methylation systems and retron activity .

• Functional parallels with other defense systems: Like other bacterial defense systems such as CRISPR-Cas and restriction-modification systems, retrons detect specific phage components to trigger defensive responses. The tripartite nature of retrons (comprising non-coding RNA, reverse transcriptase, and effector protein) represents a unique evolutionary solution to phage defense, distinct from but functionally parallel to other systems .

• Selective pressure from phage counter-defense: The evolution of retron EC67 appears to be shaped by ongoing selective pressure from phage counter-defense mechanisms like the Rad protein, representing a classical example of host-pathogen co-evolution .

What are the methodological challenges in distinguishing ORFB function from other retron components?

Researchers face several methodological challenges when attempting to isolate and understand the specific function of ORFB within the retron EC67 system:

• Interdependent component functionality: Studies of similar retron systems reveal that all three components (non-coding RNA, reverse transcriptase, and effector protein) are typically interdependent for function. For example, the Retron-Eco11 system requires its msDNA and both protein components for protective function. This interdependence makes it difficult to study ORFB in isolation without disrupting the entire system .

• Temporal coordination challenges: The defense mechanism involves a sequence of events from phage detection to defense activation. Developing experimental systems that can capture this temporal coordination is methodologically challenging.

• Functional redundancy considerations: Potential functional redundancy between different retron systems or between retrons and other defense systems complicates interpretation of knockout studies. Researchers should consider using multiple complementary approaches:

  • Point mutations rather than complete knockouts

  • Partial complementation studies

  • Domain-specific modifications

  • Heterologous expression systems

• Cross-species variability: Different bacterial species may utilize retron systems in species-specific ways, making generalization from model systems problematic. When studying ORFB, consider validating findings in multiple bacterial backgrounds .

How can researchers validate antibody specificity for ORFB protein studies?

To ensure antibody specificity when studying the Putative uncharacterized protein ORFB, researchers should implement this comprehensive validation workflow:

• Western blot analysis:

  • Test against recombinant ORFB protein (>85% purity by SDS-PAGE)

  • Include both positive controls (recombinant ORFB) and negative controls (lysates from strains lacking the retron EC67)

  • Verify a single band at the expected molecular weight (~18.5 kDa based on the 169 amino acid sequence)

• Immunoprecipitation validation:

  • Perform pull-down experiments followed by mass spectrometry identification

  • Confirm protein identity through peptide mass fingerprinting

  • Assess non-specific binding using pre-immune serum controls

• Cross-reactivity assessment:

  • Test against closely related retron proteins

  • Evaluate potential cross-reactivity with E. coli Dam methylase (which shows sequence similarity in the retron region)

  • Perform epitope mapping to identify antibody binding regions

• Functional validation:

  • Confirm antibody interaction does not interfere with protein function

  • Test antibody in immunofluorescence to verify subcellular localization patterns

  • Perform immunodepletion experiments to assess functional impact

What are the common pitfalls in experimental design when studying retron systems?

Researchers should be aware of these common experimental pitfalls when studying retron systems:

How can contradictory data about ORFB function be reconciled in research contexts?

When faced with contradictory data regarding ORFB function, researchers should apply these systematic resolution strategies:

• Context-dependent function analysis:

  • Evaluate whether contradictions arise from different experimental contexts (host strains, temperature, growth conditions)

  • Test ORFB function in standardized conditions across different labs to establish reproducibility

  • Document all experimental variables that might influence outcomes

• Phage-specific response patterns:

  • Consider that ORFB may have different effects depending on the challenging phage

  • Create a comprehensive phage response profile for ORFB activity

  • Test the hypothesis that different phages may trigger different aspects of ORFB function

• Component interaction network mapping:

  • Develop interaction networks between ORFB and other retron components

  • Test whether contradictory results stem from variable expression levels of other components

  • Use systems biology approaches to model the complete retron system behavior

• Evolutionary context integration:

  • Compare ORFB function across different bacterial strains harboring retron EC67

  • Consider whether selective pressures from different phage populations could explain functional differences

  • Apply comparative genomics to identify conserved vs. variable regions that might explain functional plasticity

What statistical approaches are most appropriate for analyzing ORFB-phage interaction data?

When analyzing data from ORFB-phage interaction studies, researchers should consider these statistical approaches:

• Phage plaque assays:

  • Use Poisson distribution models to analyze plaque formation

  • Apply non-parametric tests when comparing plaque sizes

  • Calculate efficiency of plating (EOP) with 95% confidence intervals

  • Consider mixed-effects models when testing across multiple bacterial strains

• Survival and growth curve analysis:

  • Apply time-series analysis for bacterial growth curves

  • Use survival analysis techniques (Kaplan-Meier) for time-to-lysis experiments

  • Implement area under the curve (AUC) analysis for comparative growth patterns

  • Consider GEE (generalized estimating equations) for repeated measures designs

• Molecular interaction quantification:

  • Apply binding kinetics models (ka, kd, KD) for interaction strength

  • Use statistical tests appropriate for binding site identification (FDR correction for multiple testing)

  • Consider bootstrapping approaches for error estimation in complex binding models

• Multiple phage comparison:

  • Implement multivariate analysis when comparing responses across phage types

  • Use cluster analysis to identify patterns in phage response

  • Consider dimensionality reduction techniques for complex datasets

  • Apply Bayesian models when integrating prior knowledge about phage-host interactions

How can researchers interpret contradictory results between in vitro and in vivo ORFB studies?

When faced with discrepancies between in vitro and in vivo studies of ORFB function, researchers should consider these interpretive frameworks:

• Physiological context differences:

  • In vitro studies may lack key cellular components that modify ORFB function

  • In vivo systems provide the complete cellular environment but introduce additional variables

  • Reconciliation approach: Develop increasingly complex in vitro systems that incorporate additional cellular components to bridge the gap

• Concentration and stoichiometry variations:

  • In vitro studies often use non-physiological protein concentrations

  • In vivo expression levels may fluctuate based on cellular conditions

  • Reconciliation approach: Titrate protein levels in both systems and develop dose-response curves

• Temporal dynamics considerations:

  • In vitro studies typically measure endpoints rather than dynamic processes

  • In vivo systems capture the complete temporal sequence of interactions

  • Reconciliation approach: Develop time-resolved in vitro assays that can capture interaction dynamics

• Interaction network completeness:

  • In vitro studies may focus on binary interactions missing the broader network effects

  • In vivo systems include all potential interaction partners but make specific interactions harder to isolate

  • Reconciliation approach: Gradually increase system complexity in vitro while using specific inhibitors or knockdowns in vivo